ACP-196, Active metabolite
Showing 1 - 25 of >10,000
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Scottsdale, Jacksonville, Rochester (drug, other, biological)
Recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Acalabrutinib
- +4 more
-
Scottsdale, Arizona
- +2 more
Jan 5, 2023
Chronic Lymphoid Leukemia Trial in Germany (Bendamustine, Obinutuzumab, Acalabrutinib)
Active, not recruiting
- Chronic Lymphoid Leukemia
- Bendamustine
- +3 more
-
Dresden, Germany
- +16 more
Nov 8, 2022
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Relapsed Chronic Lymphocytic Leukemia Trial in Boston (Acalabrutinib,
Active, not recruiting
- Chronic Lymphocytic Leukemia
- +3 more
- Acalabrutinib
- +2 more
-
Boston, MassachusettsDana Farber Cancer Institute
Dec 19, 2022
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia Trial in Columbus (acalabrutinib,
Active, not recruiting
- Chronic Lymphocytic Leukemia
- +2 more
- acalabrutinib
- +3 more
-
Columbus, OhioResearch Site
Mar 11, 2022
Advanced Haematological Malignancies Trial in Worldwide (AZD4573, Acalabrutinib)
Recruiting
- Advanced Haematological Malignancies
-
Duarte, California
- +38 more
Jul 22, 2022
Chronic Lymphocytic Leukemia Trial in Worldwide (Acalabrutinib, Venetoclax, Chemoimmunotherapy)
Recruiting
- Chronic Lymphocytic Leukemia
- Acalabrutinib
- +3 more
-
Fountain Valley, California
- +201 more
Jan 16, 2023
Activated B-cell DLBCL (ABC DLBCL) Trial in United Kingdom, United States (Acalabrutinib)
Active, not recruiting
- Activated B-cell Diffuse Large B-Cell Lymphoma (ABC DLBCL)
-
Los Angeles, California
- +6 more
Dec 1, 2022
Waldenström Macroglobulinemia (WM) Trial in Worldwide (Acalabrutinib (ACP-196))
Active, not recruiting
- Waldenström Macroglobulinemia (WM)
- Acalabrutinib (ACP-196)
-
Santa Barbara, California
- +37 more
Mar 17, 2022
Chronic Lymphocytic Leukemia Trial in Columbus, Hermitage, Fort Worth (acalabrutinib, ACP-319)
Active, not recruiting
- Chronic Lymphocytic Leukemia
-
Columbus, Ohio
- +1 more
Jan 20, 2022
Palliative Care Trial in Hong Kong (ACP-Family)
Not yet recruiting
- Palliative Care
- ACP-Family
-
Hong Kong, Hong KongShatin Hospital
Jun 29, 2023
Healthy Volunteers Trial in Lincoln (ACP-196, Omeprazole)
Completed
- Healthy Volunteers
-
Lincoln, NebraskaLaura Sterling, MD, MPH
May 5, 2021
Chronic Lymphocytic Leukemia Trial in Worldwide (Acalabrutinib)
Active, not recruiting
- Chronic Lymphocytic Leukemia
-
Chandler, Arizona
- +107 more
Mar 8, 2022
Surgical Advanced Care Planning Trial in San Francisco (Increasing intensity of ACP-related messaging prior to surgical visit)
Not yet recruiting
- Surgical Advanced Care Planning
- Increasing intensity of ACP-related messaging prior to surgical visit
-
San Francisco, CaliforniaUniversity of California, San Francisco
Oct 13, 2023
MCL, Mantle Cell Lymphoma Trial in Worldwide (Acalabrutinib-rituximab in patients with untreated mantle cell lymphoma)
Recruiting
- MCL
- Mantle Cell Lymphoma
- Acalabrutinib-rituximab in patients with untreated mantle cell lymphoma
-
Odense, Denmark
- +21 more
Feb 11, 2022
Healthy Volunteers Trial in Madison (Acalabrutinib, Microtracer [14C]ACP-196)
Completed
- Healthy Volunteers
- Acalabrutinib
- Microtracer [14C]ACP-196
-
Madison, WisconsinCovance Clinical Research Unit, Inc.
May 21, 2021
Alzheimer, Dementia Trial in Warsaw, Louisville, Kennett Square (ACP Specialist Program)
Completed
- Alzheimer Disease
- Dementia
- ACP Specialist Program
-
Warsaw, Indiana
- +1 more
Jan 3, 2023
COVID-19 Trial in Worldwide (BRII-196, BRII-198, Placebo)
Completed
- COVID-19
- BRII-196
- +3 more
-
Tucson, Arizona
- +106 more
Mar 24, 2023
Family Members, Nursing Home, Older Adults Trial in Hong Kong (a Nurse-led, Motivational Interview)
Completed
- Family Members
- +2 more
- a Nurse-led, Motivational Interview
-
Hong Kong, Hong KongThe University of Hong Kong
Jun 13, 2023
Arterial Hypertension, Pulmonary Trial in Germany, Poland (Macitentan)
Recruiting
- Arterial Hypertension, Pulmonary
-
Freiburg im Breisgau, Germany
- +3 more
Feb 9, 2023